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Abstract 
Objective: To examine the IFN- γ levels in patients with periodontitis and determine the 
difference in the levels of IFN-γ with the severity of the disease. Material and Methods: The 
study design was cross-sectional, and the sample consisted of 31 patients, aged between 18 and 
64 years. Plaque index (PlI), calculus index (CI), and papillary bleeding index (PBI) were 
measured. Pocket depth (PD), recession, and clinical attachment loss (CAL) (mm) were measured 
at six sites per teeth. For mild/moderate periodontitis, pocket depth ≥4 mm in 1–3 sites was 
required, while the essential criteria for severe periodontitis were pocket depth ≥5 mm, clinical 
attachment loss >3 mm in more than 3 sites ≥2 quadrants. The IFN-γ levels were measured by 
performing enzyme-linked immunosorbent assay with the gingival crevicular fluid (GCF) 
samples. The measurements were made in two different sites, and the severity of periodontitis 
was categorized based on the pocket depth, attachment loss, and the remaining natural teeth. 
Kruskal-Wallis test, Mann-Whitney test, and Spearman’s rank correlation coefficient were. 
Results: The levels of IFN-γ (pg/mL) were correlated with the severity of the periodontal status, 
with p <0.05. Clinical parameters of periodontitis also correlated with the level of IFN-γ 
(pg/mL). Conclusion: Subjects with periodontitis presented greater levels of IFN-γ (pg/mL) in 
GCF than the periodontal healthy individuals. This result showed the role of IFN-γ in the 
inflammation. 
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Introduction 
In Indonesia, periodontal diseases had a fairly high prevalence of 95.2% in the year 2015 [1]. 
The illness has a multifactorial etiology, with environmental, systemic, host, and pathogen-specific 
(bacteria and/or viruses) factors contributing to it. Pathogenic bacteria present in the subgingival 
biofilms are associated with immune response in the susceptible host, resulting in periodontal tissue 
damage. Microbial presence triggers the production of cytokines by the gingival epithelium, while 
the cytokine imbalance results in uncontrolled inflammation and leads to tooth loss in adult 
populations [2]. 
Periodontitis is a chronic pathological condition characterized by gingival inflammation and 
the destruction of tooth support structures. The development of chronic periodontitis can be 
attributed to the multifactorial interactions between the microbe and the host immune system. 
According to the new periodontal classification, the two main forms of the disease were chronic and 
aggressive periodontitis. The severity level ranges from 1 to 4, while the grading based on the 
progression rate was grade A (slow), B (moderate), and C (rapid) [3]. In these studies, chronic 
periodontitis was referred to as periodontitis, with initial or moderate periodontitis and severe 
periodontitis, where the extent and distribution were localized and generalized. 
T-cell-mediated immune response, involving killer T-cells and T-helper (Th) cells, plays a 
role in tackling the disease [4]. Cells such as macrophages recognize the microorganism and trigger 
the expression of proinflammatory genes. This occurs through nuclear factor kB (NF-kB) 
transcriptional activation and/or the expression of antiviral mediators, such as interferons, via 
interferon regulatory factors. This process results in the release of proinflammatory cytokines, 
chemokines, and antimicrobial effectors [5]. 
Interferon-gamma (IFN-γ) is type-II interferon whose structure is different from that of type 
I and type III interferons, and it gives signals through specific receptors [6]. IFN-γis triggered by 
interleukin (IL)-12 and IL-18 cytokines released by the immune cells, including CD4+ Th1 cells, 
cytotoxic CD8+ cells, and natural killers, such as macrophages and dendritic cells (DCs) [7]. 
The main function of Th1 cytokines, that is, IL-2 and IFN-γ, is to increase cell-mediated 
response, whereas the IL2-Th2 cytokine suppresses the response [8]. Cytokine IFN-γ was 
considered the main activator phagocyte and associated with the production of inflammatory 
cytokines and chemokines, although it also systematically inhibit osteoclastogenesis and stimulates 
the formation of osteoclast in vivo [9]. 
In the affected tissues, local inflammatory progression determines the conditions of the 
disease. Cytokines and chemokines direct the migration of leucocytes to the periodontal tissue, where 
these cells become involved in the destruction of pathogenic bacteria by releasing mediators of local 
inflammatory responses [10]. Therefore, detecting increased levels of this mediator in the gingival 
crevicular fluid (GCF), saliva, and blood was considered to be a biomarker for some aspects of 
periodontal disease [11]. Increased cytokine levels in the saliva and GCF of individuals with 
periodontal disease are pathological markers [12]. GCF is a physiological fluid and an inflammatory 
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exudate. This secretion is derived from the vascular flexing in the gingival corium, close to the edges 
of the epithelium, in the space between the tooth and the gingiva. GCF changes from the normal 
clinical tissue to serum transudate during inflammation, when the disease becomes clinically 
apparent. Therefore, GCF can be used as a diagnostic and prognostic tool in periodontal disease 
[11]. 
A previous study on the serum levels of IFN-γ and IL-4 in individuals with chronic 
periodontitis revealed wide variations in the cytokine concentrations, with the levels being quite low 
in serum samples with chronic periodontitis, thereby making it impossible to describe the severity of 
the disease [12]. In a GCF study, the IL-17 levels were declined, while the IFN-γ and IL-10 levels 
remained unchanged after dental plaque clearance within 8 weeks, 16 weeks and 24 weeks [14], in 
line with another study that no difference in IFN-γ serum concentration at baseline and 6 months 
post-therapy [15]. In contrast, high levels of IL-1-𝛼, IL-1β, TNF-α, IL-6, IFN-γ, IL-4, and IL-10 in 
the gingival tissue, strongly illustrate the severity of the periodontal disease in Chinese subjects 
[16]. This observation was in agreement with a work in which IFN-γ level in GCF and T-bet 
expression was elevated in individuals with chronic periodontitis. T-bet is a T-Box transcription 
factor, expressed in T cells and required for differentiation of IFN-γ secretion by CD4+ Th1 T cells 
[17,18]. Sixteen proinflammatory and four anti-inflammatory cytokines, including IFN-γ, were 
significantly elevated in GCF of chronic periodontitis patients, facilitating the protective role of IFN-
γ and IL-10 [19]. 
Since previous studies have yielded conflicting results, this issue needs to be investigated 
further. The present research was conducted to measure the level of IFN-γ in individuals with and 
without periodontitis, while the correlation between the IFN-γ level and the disease was also 
examined. We suggest that there is an increase in IFN-γ level according to the severity of 
periodontitis. 
 
Material and Methods 
Study Design and Sample 
The study design was cross-sectional, and the sample consisted of 31 patients, aged between 
18 and 64 years, who visited the Dental and Oral Hospital in Universitas Yarsi from March to May 
2018 and who matched the inclusion criteria. 
The inclusion criteria were: (1) male and female Indonesian patients aged 18-64 years; (2) 
absence of immunodeficiency disorder and autoimmune disease; (3) no prior periodontal therapy and 
no antibiotics or non-steroidal anti-inflammatory drugs used for a period of 3 months prior to the 
study; and (4) the presence of at least 14 natural teeth. The exclusion criteria were 
pregnant/lactating women and dental conditions necessitating antibiotics.  
 
Clinical Parameters and GCF Collection 
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The status of oral hygiene and gingival inflammation was assessed by using the Plaque index 
(PlI) [20], calculus index (CI) [21], and papillary bleeding index (PBI) [22] in Ramfjord teeth. The 
clinical parameters of periodontitis were evaluated as the levels (in mm) of pocket depth (PD), 
recession, and clinical attachment loss (CAL). With the WHO pocket probe, the measurements 
included all teeth except for the third molar, six sites per tooth (distobuccal, midbuccal, mesiobuccal, 
mesiolingual, midlingual, and distolingual). A single qualified examiner conducted the clinical 
measurements. 
The criteria for periodontal health were the presence of at least 26 natural teeth, ≤1 site with 
pocket depth ≥3 mm, general pocket depth ≤3 mm, no clinical attachment loss, and no teeth 
mobility. The periodontitis criterion was the presence of at least 14 natural teeth. For mild/moderate 
periodontitis, pocket depth ≥4 mm in 1–3 sites was required, while the essential criteria for severe 
periodontitis were pocket depth ≥5 mm, clinical attachment loss >3 mm in more than 3 sites ≥2 
quadrants. The healthy periodontal was grouping with the mild periodontitis and compared to the 
severe periodontitis. 
Phosphate-buffered saline (PBS) was prepared by dissolving 1 tablet in 100 mL of distilled 
water; subsequently, 1 mL of the solution was transferred into an Eppendorf tube and placed in a 
cooler box. GCF was obtained from patients by a paper point after supragingival plaque removal by 
using a cotton pellet. Then, the tooth being examined was isolated using a cotton roll and dried 
gently. The sample was collected using paper point ISO 30 (Roeko GmbH, Langenau, Germany) by 
inserting it into the mid buccal pocket carefully until resistance was felt, then maintaining it for 30 s. 
Blood or saliva contaminated paper points were discarded. Four paper points per site from two 
different quadrants were pooled in the Eppendorf tube containing PBS and transferred to the 
laboratory in a cooler box. 
 
Enzyme-Linked Immunosorbent Assay 
GCF samples were analyzed for the level of IFN-γ by using ELISA. The sample was 
vortexed, then centrifuged at 1000 g (5000 rpm) for about 15 min. The supernatant was taken, and 
the sample was stored at -20°C for further analysis. 
ELISA (MyBioSource, San Diego, CA) was performed for the quantitative detection of IFN-
γ, according to the manufacturer’s recommendation. For this procedure, 100 µL of detection antibody 
was added to the wells, mixed gently, covered with strips of membrane plates, and incubated at 37°C 
for 60 min. The wells were washed four times with the wash buffer. The plate frame was held firmly, 
inverted, and tapped onto absorbent papers or paper towels to remove any remaining buffer. Each of 
the chromogen solutions A and B (50 µL each) were added. The wells were protected from light 
using a well cover and aluminum foil, followed by incubation at 37°C for 15 min. 
Later, the reaction was stopped by adding 50 µL of stop solution to each well. The color 
changed from blue to yellow. The optical density was read at 450 nm using a microplate reader 
(Vmax®, Molecular Devices, LLC, San Jose, CA, USA) with the SoftMax Pro Software (Molecular 
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Devices, LLC, San Jose, CA, USA). The concentration of each sample was calculated using a 
standard curve (7.8–1000 pg/mL). Values lower than the detection limit (<4.1 pg/mL in our assay) 
were considered undetectable. 
 
Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics, version 23 (IBM Corp., 
Armonk, New York, USA). Normality was checked with a Shapiro-Wilk test; as the data distribution 
was not homogeneous, the analysis was performed using non-parametric tests. Kruskal-Wallis test 
was employed for comparison between the periodontal status and the levels of IFN-γ (pg/mL). If a 
significant difference was found, the variations between the groups were assessed using a Mann-
Whitney test. The Spearman’s rank correlation coefficient was used to analyze the correlation 
between IFN-γ level (pg/mL) and the periodontal status, clinical disease parameter, and risk factor; 
p<0.05 was considered statistically significant. 
 
Ethical Aspects 
The study was approved by the Ethics Committee of the Faculty of Dentistry, Universitas 
Yarsi (No. 207/KEP-UY/BIA/IX/2017) and the research was performed in accordance with the 
recommendations of the Helsinki Convention, and that positive opinion of the local Bioethics 
Committee has been sought and obtained. The subjects were instructed about the purpose and 
procedure of the study, and informed consent was obtained from each patient. 
 
Results 
The results of this study were obtained 62 samples. The demographic data, including 
distribution of the gender, smoking status, and periodontal status, are presented in Table 1. 
 
Table 1. Sample distribution according to demographic and clinical characteristics. 
Variables Value 
Age (Years) (Mean ± SD) 35.66 ± 13.56 
Periodontal Status  
Healthy Periodontal and Mild Periodontitis 32 (32.88 ± 12.0) 
Severe Periodontitis 30 (38.63 ± 14.6) 
Gender  
Male 22 (35.5) 
Female 40 (64.5) 
Smoking Status  
No Smoking 51 (82.3%) 
Smoking/ Previous Smokers 11 (17.7%) 
Plaque Index (Mean ± SD) 1.56 ± 0.78 
Calculus Index (Mean ± SD) 1.92 ± 0.71 
Papilla Bleeding Index (mm) (Mean ± SD) 1.97 ± 1.05 
Pocket Depth (mm) (Mean ± SD) 2.2 ± 0.84 
Recession (mm) (Mean ± SD) 0.19 ± 0.44 
Clinical Attachment Loss (mm) (Mean ± SD) 1.30 ± 1.09 
Number Natural Teeth (mm) (Mean ± SD) 25.66 ± 3.57 
Level of IFN-γ (pg/ml) (Mean ± SD) 729.33 ± 598.63 
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The level of IFN-γ in healthy periodontal and mild periodontitiswas448.267± 450.45, and 
severe periodontitis was 1029.13 ± 597.27 pg/mL, respectively (p<0.001) (Figure 1). 
 
 
Figure 1. GCF cytokine concentrations of IFN-γ (pg/ml) in healthy periodontal and mild periodontitis 
and severe periodontitis. Boxplots present the median, minimum, maximum values. Differences among 
the groups (Mann-Whitney; **p<0.001). 
 
The correlation between factors, such as age and gender, smoking status with IFN-γ (pg/) 
levels were given in Table 2. Positive moderate correlations were found in PlI, PBI, PD, and 
periodontal status, while CI, CAL showed a weak correlation with the IFN-γ (pg/mL) levels. The 
other factors were not significantly correlated with the level of IFN-γ. 
 
Table 2. Correlation between the demographic, clinical parameter of periodontitis, 
and the level of IFN-γ. 
Variable IFN-γ Level of IFN-γ pg/ml 
 r p-value 
aAge  0.185 0.149 
aGender 0.122 0.343 
aSmoking Status 0.136 0.293 
aPlaque Index 0.449 0.000** 
aCalculus Index 0.381 0.002* 
aPapilla Bleeding Index 0.514 0.000** 
bPocket Depth 0.469 0.000** 
aRecession 0.248 0.052 
aClinical Attachment Loss 0.343 0.006* 
aNumber of Natural Teeth 0.091 0.481 
aPeriodontal Status 0.451 0.000** 
aSpearman Correlation test (p<0.05); bPearson Correlation test (p<0.05). 
 
Discussion 
The present findings showed statistically significant results between the healthy periodontal 
and periodontitis that support reports of previous investigations that had detected IFN-γ (pg/mL) 
with higher frequency in periodontitis patients than in healthy periodontal, but the sample was taken 
from serum [10]. This study was also in line with other studies that reported an increased level of 
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IFN-γ, along with IL-10 [23], and elevated IFN-γ concentration and T-bet expression in 
periodontal tissue and depicted increased severity of the disease as the active sites revealed higher 
concentrations than inactive sites; hence, it was speculated that cytokine is involved in the 
inflammatory response [17]. 
A significant correlation was observed between the clinical parameters of periodontitis and 
the level of IFN-γ, as in a previous report [10]. In a clinical study, the level IFN-γ in the GCF of 
patients with periodontitis before and after the treatment yielded different results. There was no 
difference in the IFN-γ levels before and after plaque removal, although all clinical parameters 
showed improvement [14,15] but another study presented a decreased amount of IFN-γ [24] and an 
increased ratio of IL-4 to IFN-γ after treatment, which indicates higher levels of IFN-γ during active 
periodontitis and decreased levels after the inflammation subsides [23]. The higher level of IFN-γ in 
periodontitis was explained by a previous study on the basis of the activation of CD4+ cells and 
enhanced expression of IFN-γ and IL-2 in aggressive periodontitis when compared with 
periodontally healthy individuals [25]. The levels of IFN-γ in our study were not related to age and 
sex; this result agrees with that of certain previous studies [17,26] and contradicts others that 
documented a correlation between IFN-γ and age [10]. 
IFN-γ is only one of the proinflammatory mediators that have an influence on the severity of 
periodontitis. The levels of 10 influential cytokines in the GCF have been studied simultaneously to 
assess their effects on periodontitis. The results stated that IL-1α, IL-1β, and IL-17A levels in the 
GCF were the best biomarkers for chronic periodontitis by combining IFN-γ and IL-10 [19]. In 
research involving many of these cytokines, age, smoking status, and periodontal severity markers 
(PD, PBI, BPL [bacterial plaque level], and CAL) had significant effects, while sex and remaining 
teeth had no effect. This difference might be attributed to the fact that the number of subjects in our 
study was smaller and less diverse, and that 20 paper points representing all the teeth were collected 
in one examination while in this study, four paper points representing each site was obtained from 
only two different quadrants per patient. 
The previous study about the role IFN-γ gene showed the inhibition of osteoclastogenesis by 
Neopterin, chemical group, which synthesized upon stimulation IFN-γ by human macrophages as an 
important factor in GCF and response of inflammation in periodontitis [27]. 
The smoking status in this research showed no significant association, as seen in an earlier 
study, between the IFN-γ (pg/mL) levels of smokers and non-smokers [28], while in another study, 
smoking was very important and showed significant result [19]. 
A meta-analysis indicated the role of IFN-γ and its variations in GCF; however, it did not 
provide a conclusive result as some studies showed high levels of IFN-γ in the healthy sites, while 
others pointed to an increased frequency in the periodontitis site [7]. This result was important in 
helping us understand that further study is needed to elucidate the exact roles of IFN-γ in GCF. 
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The present study faced some limitations, as the samples were small and other anti-
inflammatory cytokines were not included. Hence, the present study could be considered as a 
preliminary study that needs to be expanded upon in order to provide a comprehensive result. 
 
Conclusion 
Subjects with periodontitis presented greater levels of IFN-γ (pg/mL) in GCF than the 
periodontal healthy individuals. This result showed the role of IFN-γ in the inflammation. 
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